醫(yī)學(xué)全在線
醫(yī)學(xué)全在線首頁-醫(yī)師-藥師-護士-衛(wèi)生資格-高級職稱-考試題庫-網(wǎng)校-考研-圖譜-下載-招聘  
分類
國家級省級浙江省各省雜志
科技核心北大核心CSCDCSCD擴展
工具
期刊知識寫作指導(dǎo) 論文投稿推薦期刊
期刊驗證論文檢測 錄用通知往期目錄
SCI
SCI指導(dǎo)影響因子
期刊點評基金動態(tài)
其它
經(jīng)濟教育計算機
建筑體育農(nóng)業(yè)
北京|天津|河北|山西|湖北|江蘇|安徽|山東|上海|浙江|江西|福建|湖南|寧夏|內(nèi)蒙古|河南
四川|重慶|貴州|云南|遼寧|吉林|廣東|廣西|海南|陜西|甘肅|新疆|青海|衛(wèi)生部直屬|黑龍江|兵團
您現(xiàn)在的位置: 醫(yī)學(xué)全在線 > 醫(yī)學(xué)論文 > 論文投稿 > 正文:醫(yī)學(xué)免費論文:丹奧對非ST段抬高急性心肌梗死患者血液流變學(xué)及血漿內(nèi)皮素和一氧化氮的影響
    

醫(yī)學(xué)免費論文:丹奧對非ST段抬高急性心肌梗死患者血液流變學(xué)及血漿內(nèi)皮素和一氧化氮的影響

來源:本站原創(chuàng) 更新:2013-10-18 論文投稿平臺

醫(yī)學(xué)免費論文:丹奧對非ST段抬高急性心肌梗死患者血液流變學(xué)及血漿內(nèi)皮素和一氧化氮的影響

【摘要】 目的 觀察奧扎格雷鈉(丹奧)對非ST段抬高心肌梗死(NSTEMI)患者血液流變學(xué)指標(biāo)、血漿內(nèi)皮素和一氧化氮的影響,探討其治療價值 。方法 81例非ST段抬高的急性心肌梗死患者隨機分為對照組和觀察組,對照組使用單硝酸異山梨酯、低分子肝素辛伐他汀,觀察組在對照組治療的基礎(chǔ)上加用奧扎格雷鈉,觀察其臨床療效和血液流變學(xué)指標(biāo)及血漿內(nèi)皮素(endothelin, ET)和一氧化氮(nitrogen monoxidum, NO)的變化。結(jié)果 觀察組療效優(yōu)于對照組(P<0.05)。治療后觀察組與對照組ET水平均較治療前明顯降低(P<0.05),NO水平均較治療前升高(P<0.05);且治療后觀察組ET、NO水平均較對照組改變明顯(P<0.05)。治療后觀察組各項血液流變學(xué)指標(biāo)均低于治療前(P<0.05);對照組僅全血比黏度高切、血小板黏附率、纖維蛋白原低于治療前(P<0.05);治療后觀察組各項指標(biāo)均低于對照組(P<0.05)。結(jié)論 奧扎格雷鈉能有效改善非ST段抬高急性心肌梗死患者的血液流變學(xué)指標(biāo)和ET、NO水平,在常規(guī)治療的基礎(chǔ)上加用奧扎格雷鈉能起到更好的治療效果。

【關(guān)鍵詞】 奧扎格雷鈉;血液流變學(xué);內(nèi)皮素;一氧化氮;非ST段抬高心肌梗死

The effect of sodium ozagrel injection on hemorheology,

endothelin and nitrogen monoxidum of patients with nonST

segment elevation myocardial infarction醫(yī).學(xué)全.在.線網(wǎng)站m.zxtf.net.cn

YUAN Yu, ZHANG Jinying, LIU Ping

1. The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052;2. Department of Cardiovascularology, the First Affiliated Hospital of XinxiangMedical University, Weihui 453100; 3. Department Two of Encephalopathy,

the Affiliated Hospital of Henan Traditional Chinese Medical College, Zhengzhou 450000, China

ABSTRACT: Objective To investigate the effect of sodium ozagrel injection on hemorheology, endothelin (ET) and nitrogen monoxidum (NO) of patients with nonST segment elevation myocardial infarction (NSEMI). Methods A total of 81 NSEMI patients were divided randomly into two groups: control group and experimental group. Isosorbide mononitrate, low molecular heparin and simvastatin were administered in the control group while sodium ozagrel was added to the experimental group apart from the abovementioned drugs. The clinical effect of sodium ozagrel was observed. The changes in the indexes of hemorheology, ET and NO were analyzed. Results The clinical effect was significantly better in the experimental group than in the control group (P<0.05). The level of ET was obviously lower after treatment than that in the experimental group and the control group before treatment (P<0.05). The level of NO was obviously higher after treatment than that in the experimental group and the control group before treatment (P<0.05). The changes of ET and NO in the experimental group posttreatment were more significant than those in the control group aftertreatment (P<0.05). The level of hemorheology index after treatment was lower than that before treatment in the experimental group (P<0.05). Highshear rate of whole blood viscosity, platelet adherence rate, and fibrin as hemorheology indexes were lower aftertreatment than those pretherapy in the control group (P<0.05). Conclusion Sodium ozagrel injection could affect hemorheology,ET and NO of patients with nonST segment elevation myocardial infarction. Thefore, the therapeutic efficacy can be better if sodium ozagrel is added to the conventional therapy.

KEY WORDS: sodium ozagrel injection; hemorheology; nitrogen monoxidum; nonST segment elevation myocardial infarction


[1] [2] [3] [4] [5] 下一頁

...
關(guān)于我們 - 聯(lián)系我們 -版權(quán)申明 -誠聘英才 - 網(wǎng)站地圖 - 網(wǎng)絡(luò)課程 - 幫助
醫(yī)學(xué)全在線 版權(quán)所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP備12017320號
百度大聯(lián)盟認(rèn)證綠色會員實名網(wǎng)站 360認(rèn)證可信網(wǎng)站 中網(wǎng)驗證